Related Experiment Video
Updated: Nov 2, 2025

Dissecting Multi-protein Signaling Complexes by Bimolecular Complementation Affinity Purification BiCAP
Published on: June 15, 2018
Stable and EGF-Induced Temporal Interactome Profiling of CBL and CBLB Highlights Their Signaling Complex Diversity
Jie Liu1,2, Lijun Yang1,2, An He3
1Department of Oncology, The Second Clinical Medical College, Jinan University (Shenzhen People's Hospital), Shenzhen 518020, China.
Abstract:
The epidermal growth factor receptor (EGFR) signal modulates cell proliferation, migration, and survival. Aberrant activation of EGFR constitutes the major cause of various cancers. Receptor ubiquitination and degradation mediated by CBL proteins play negative regulatory roles and control the intensity and duration of the signaling. With the construction of stable cell lines inducibly expressing FLAG-tagged CBL or CBLB, we identified 102 and 82 stable interacting proteins of CBL and CBLB, respectively, through the affinity purification followed by mass spectrometry (AP-MS) approach. Time-resolved profiling at six different time points combined with functional annotations of the temporal interactomes provides insights into the dynamic assembly of signal proteins upon EGFR signaling activation. Comparison between the interactomes of CBL and CBLB indicates their redundant but also complementary functions. Importantly, we validated the stable association of EPS15L1 and ITSN2 and temporal association of TNK2 to both CBL and CBLB through biochemical assays. Collectively, these results offer a useful resource for CBL and CBLB interactomes and highlight their prominent and diverse roles in the EGFR signaling network.
Insights
This study identifies proteins interacting with CBL and CBLB, crucial regulators of epidermal growth factor receptor (EGFR) signaling. The findings reveal redundant and complementary functions of CBL and CBLB in controlling cancer-related cell activities.
Area of Science:
- Cell Biology
- Molecular Oncology
- Signal Transduction
Background:
- Epidermal growth factor receptor (EGFR) signaling is vital for cell functions but its aberrant activation drives cancer.
- CBL proteins (CBL and CBLB) negatively regulate EGFR signaling through ubiquitination and degradation, controlling signal duration and intensity.
Purpose of the Study:
- To identify and characterize the protein interactomes of CBL and CBLB.
- To understand the dynamic assembly of signaling proteins in response to EGFR activation.
- To elucidate the functional relationship between CBL and CBLB in EGFR signaling.
Main Methods:
- Stable inducible expression of FLAG-tagged CBL and CBLB in cell lines.
- Affinity purification followed by mass spectrometry (AP-MS) to identify interacting proteins.
- Time-resolved proteomic profiling across six time points.
- Biochemical assays for validating protein associations.
Main Results:
- Identified 102 stable interacting proteins for CBL and 82 for CBLB.
- Temporal profiling revealed dynamic protein assembly during EGFR signaling.
- Demonstrated redundant and complementary functions of CBL and CBLB.
- Validated interactions with EPS15L1, ITSN2, and TNK2.
Conclusions:
- The study provides a comprehensive resource of CBL and CBLB interactomes.
- Highlights the significant and varied roles of CBL and CBLB in the EGFR signaling network.
- Offers insights into the regulation of cell proliferation, migration, and survival in cancer contexts.
Related Concept Videos
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Intracellular Signaling Affects Focal Adhesions
Some...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
TGF - β Signaling Pathway

